TABLE 4

Changes with ambient air versus hyperoxia for all disease groups are shown at isotime

IsotimeMean differences (95% CI) with hyperoxia
HealthyPVDCOPDHFpEFCHD
IET
SpO2 %3.0 (2.1–4.3)***9.0 (5.2–10.9)***4.6 (2.9–6.4)***5.0 (3–6)**6.0 (2.3–9.4)*
VE L·min−1−16.0 (−16.9– −1.3)*−9.0 (−13.1– −2.2)*−3.3 (−6.3– −2.2)***2.0 (−9.9–13.9)−4.9 (−8.3– −1.4)*
Heart rate bpm−7.0 (−7.4– −2.1)**−5.0 (−10.2– −4.3)***−5.0 (−8.4– −1.3)*−3.0 (−8.2–1.3)−6.0 (−15.3–4.2)
VE/VCO2−3.5 (−3.6– −1.7)***−5.1 (−6.8– −3.5)***−3.2 (−4.9– −2.1)***−3.8 (−5.1– −2.4)**−3.6 (−5.2– −2.1)**
CWRET
SpO2 %3.0 (0.6–4)***9.2 (5.8–12.6)***5.2 (3.1–7.3)***4.0 (1.0–8.0)*5.0 (3.0–6.7)**
VE L·min−1−11.0 (−14.8– −3.1)***−10.5 (−18.5– −1.9)*−7.5 (−8.5– −4.1)***−8.5 (−10– −7.1)***−4.9 (−13.1–3.4)
Heart rate bpm−3.0 (−4.9– −0.8)**−11.0 (−15.2– −4.5)**−8.0 (−10.4– −3.8)***−5.0 (−8.1– −0.9)*−4.0 (−9.4–0.5)
VE/VCO2−3.0 (−4.1– −2.3)***−8.2 (−10.3– −6.1)***−14.0 (−16.4– −2.8)***−5.6 (−7.4– −3.9)***−5.4 (−9.3– −1.4)*

Data are presented as mean differences with 95% confidence intervals. For more details on statistical analyses see the original publications [1317]. PVD: pulmonary vascular disease with precapillary pulmonary hypertension; COPD: chronic obstructive pulmonary disease; HFpEF: heart failure with preserved ejection fraction with postcapillary pulmonary hypertension; CHD: cyanotic congenital heart disease; IET: incremental exercise test; CWRET: constant work-rate exercise test; SpO2: oxygenation by pulse oximetry; VE: minute ventilation; VE/VCO2: ventilatory equivalent for CO2. *: p=0.05; **: p=0.01; ***: p<0.001.